COMP <GO>
CGNX vs BRK-A // RETURN ON INVESTED CAPITAL (ROIC)
Cognex Corporation (NASDAQ) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: CGNX 8
— BRK-A 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CGNX
LAST: $56.15 (-4.78%) • MKT CAP: $9.92B
roic
8.90%
LAST: $815,600.00 (-0.23%) • MKT CAP: $1.20T
roic
8.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CGNX VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CGNX | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.90% | 41.00% | +25.90 | CGNX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 8.90% | 8.30% | +0.60 | CGNX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 58.1x | 12.7x | +45.40 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 2.39% | 2.08% | +0.31 | CGNX | /fcf-yield <GO> |
| Operating Margin | 16.30% | 33.00% | -16.70 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 11.50% | 27.10% | -15.60 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | -1.00% | +9.70 | CGNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.55% | 0.00% | +0.55 | CGNX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.69 | 3.02 | +9.67 | CGNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | CGNX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.30% | -0.80 | CGNX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.0 | 67.2 | -23.16 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 1.13 | -0.25 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 80.6x | 16.7x | +63.90 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.92B | $1.20T | -$1.19T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CGNX REV | BRK-A REV | CGNX GROSS % | BRK-A GROSS % | CGNX FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $994.4M | $247.24B | 66.9% | 44.0% | $236.8M | $25.04B |
| FY 2024 | $914.5M | $249.71B | 68.4% | 44.0% | $134.0M | $11.62B |
| FY 2023 | $837.5M | $254.91B | 44.0% | 44.0% | $75.2M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CGNX // BETA 0.88
BRK-A // BETA 1.13